Thyrocare Technologies Limited — Regulatory Filings 2018

Nov 2, 2018

==> picture [52 x 301] intentionally omitted <==

ocare Thyr

Think Thyroid. Think Thyrocare.

'\o,·ember 02. 2018

The l\ational Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex. Bandra (E). Mumbai - -WO 051

The Bombay Stock Exchange Ltd Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001

Dear Sir/N1adarn.

Sub: Disclosure of information under Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations.2015 - Meeting with Investor/Analyst

--0--

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015. we ,, ish to inform you that Mr. Suney Hindocha and Mr. Edward Lam. Fund :\lanagers of Somerset Capital Management. UK. would be having a meeting with Dr. Caesar Sengupta. Vice-President-Operations. Mr. Sachin Salvi. General Manager-Finance and Mr. Anand Velumani. Director of our subsidiar[y ] company. Nueclear Healthcare Limited. at our office b� 9.30 A.:[V] I. on Thursday. O'ember 22.2018.

There could be last minute change in the names of Analysts or in the timings

Please note that no un-publ ished Price-Sensitive Information will be shared during the above meeting.

Your Faithfully.

For Thyrocare Technologies Limited,

==> picture [50 x 28] intentionally omitted <==

Ramjee Dorai Company Secreta�· and Compliance Officer

==> picture [83 x 85] intentionally omitted <==

Thyrocare Technologies L1m1ted

• 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai 400 703, India (9 022· 3090 0000 / 4125 2525 � enquiry@thyrocare.com (ll)) www.thyrocare.com

(CIN. L85110MH20 PLC123882